» Articles » PMID: 37995111

Diagnostic Accuracy of Single-Lead Electrocardiograms Using the Kardia Mobile App and the Apple Watch 4: Validation Study

Overview
Journal JMIR Cardio
Publisher JMIR Publications
Date 2023 Nov 23
PMID 37995111
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To date, the 12-lead electrocardiogram (ECG) is the gold standard for cardiological diagnosis in clinical settings. With the advancements in technology, a growing number of smartphone apps and gadgets for recording, visualizing, and evaluating physical performance as well as health data is available. Although this new smart technology is innovative and time- and cost-efficient, less is known about its diagnostic accuracy and reliability.

Objective: This study aimed to examine the agreement between the mobile single-lead ECG measurements of the Kardia Mobile App and the Apple Watch 4 compared to the 12-lead gold standard ECG in healthy adults under laboratory conditions. Furthermore, it assessed whether the measurement error of the devices increases with an increasing heart rate.

Methods: This study was designed as a prospective quasi-experimental 1-sample measurement, in which no randomization of the sampling was carried out. In total, ECGs at rest from 81 participants (average age 24.89, SD 8.58 years; n=58, 72% male) were recorded and statistically analyzed. Bland-Altman plots were created to graphically illustrate measurement differences. To analyze the agreement between the single-lead ECGs and the 12-lead ECG, Pearson correlation coefficient (r) and Lin concordance correlation coefficient (CCC) were calculated.

Results: The results showed a higher agreement for the Apple Watch (mean deviation QT: 6.85%; QT interval corrected for heart rate using Fridericia formula [QTcF]: 7.43%) than Kardia Mobile (mean deviation QT: 9.53%; QTcF: 9.78%) even if both tend to underestimate QT and QTcF intervals. For Kardia Mobile, the QT and QTcF intervals correlated significantly with the gold standard (r=0.857 and r=0.727; P<.001). CCC corresponded to an almost complete heuristic agreement for the QT interval (0.835), whereas the QTcF interval was in the range of strong agreement (0.682). Further, for the Apple Watch, Pearson correlations were highly significant and in the range of a large effect (r=0.793 and r=0.649; P<.001). CCC corresponded to a strong heuristic agreement for both the QT (0.779) and QTcF (0.615) intervals. A small negative correlation between the measurement error and increasing heart rate could be found of each the devices and the reference.

Conclusions: Smart technology seems to be a promising and reliable approach for nonclinical health monitoring. Further research is needed to broaden the evidence regarding its validity and usability in different target groups.

Citing Articles

Comparative Evaluation of Consumer Wearable Devices for Atrial Fibrillation Detection: Validation Study.

Wouters F, Gruwez H, Smeets C, Pijalovic A, Wilms W, Vranken J JMIR Form Res. 2025; 9():e65139.

PMID: 39791483 PMC: 11737281. DOI: 10.2196/65139.


Classification of Premature Ventricular Contractions in Athletes During Routine Preparticipation Exams.

Gomez S, Perez M, Wheeler M, Hadley D, Hwang C, Kussman A Circ Arrhythm Electrophysiol. 2024; 17(9):e012835.

PMID: 39193774 PMC: 11452187. DOI: 10.1161/CIRCEP.124.012835.


MEMS Technology in Cardiology: Advancements and Applications in Heart Failure Management Focusing on the CardioMEMS Device.

Ciotola F, Pyxaras S, Rittger H, Buia V Sensors (Basel). 2024; 24(9).

PMID: 38733027 PMC: 11086351. DOI: 10.3390/s24092922.

References
1.
Funck-Brentano C, Jaillon P . Rate-corrected QT interval: techniques and limitations. Am J Cardiol. 1993; 72(6):17B-22B. DOI: 10.1016/0002-9149(93)90035-b. View

2.
Beers L, van Adrichem L, Himmelreich J, Karregat E, de Jong J, Postema P . Manual QT interval measurement with a smartphone-operated single-lead ECG versus 12-lead ECG: a within-patient diagnostic validation study in primary care. BMJ Open. 2021; 11(11):e055072. PMC: 8572408. DOI: 10.1136/bmjopen-2021-055072. View

3.
Hayiroglu M, Cinier G, Yuksel G, Pay L, Durak F, Cinar T . Effect of a mobile application and smart devices on heart rate variability in diabetic patients with high cardiovascular risk: A sub-study of the LIGHT randomized clinical trial. Kardiol Pol. 2021; 79(11):1239-1244. DOI: 10.33963/KP.a2021.0112. View

4.
Muhlen J, Stang J, Skovgaard E, Judice P, Molina-Garcia P, Johnston W . Recommendations for determining the validity of consumer wearable heart rate devices: expert statement and checklist of the INTERLIVE Network. Br J Sports Med. 2021; 55(14):767-779. PMC: 8273688. DOI: 10.1136/bjsports-2020-103148. View

5.
Castiglione A, Odening K . [QT Interval and Its Prolongation - What Does It Mean?]. Dtsch Med Wochenschr. 2020; 145(8):536-542. DOI: 10.1055/a-0969-6312. View